Brain Imaging and Pain in Irritable Bowel Syndrome
Brain Imaging and Pain: Analysis of Placebo Analgesia
ClinicalTrials.gov ID
NCT00065754
Lead Sponsor
University of FloridaOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
50
Last Update Posted
Sep 20, 2011Estimated
Start Date
Sep 2003
Primary Completion Date
Dec 2007Actual
Completion Date
Dec 2007Actual
Official Title
Brain Imaging and Pain: Analysis of Placebo Analgesia
Brief Summary
This study examines the mechanisms, including brain imaging of placebo analgesia
Irritable Bowel Syndrome
placebo
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Irritable Bowel Syndrome
English speaking
Exclusion criteria:
Chronic pain condition other than Irritable Bowel Syndrome
Medical condition that would contraindicate use of lidocaine
Clinical criteria for fibromyalgia
Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
Seropositive HIV
Pregnancy
Allocation
Randomized
Interventional Model
Factorial Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
University of Florida
Gainesville, Florida 32610, United States
Lead Sponsor
University of FloridaOTHER
Collaborators
National Center for Complementary and Integrative Health (NCCIH)NIH
National Institute of Neurological Disorders and Stroke (NINDS)NIH